Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|
Gross Profit | $86.4M | $156.4M | ($331.6M) | $17.0M | $266.6M | $15.1B | $13.8B | $2,155.0M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Moderna, Inc.'s last 12-month Gross Profit is $3,345.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Moderna, Inc.'s Gross Profit growth was (2.7%). The average annual Gross Profit growth rates for Moderna, Inc. have been 36.5% over the past three years, N/A over the past five years.